Sunshine Biopharma Inc. (SBFMW) revenue by segment

SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30

$0.03+0.00 (+2.00%)

Close on Oct 30, 2026Market cap $11.36MP/E –Yield –

Sunshine Biopharma Inc. revenue by segment

Sunshine Biopharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.